BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
T cell receptor signaling pathway
,
Ischemia
,
Neuron
,
Pharmacogenetics
,
Doxorubicin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ependymoma
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
STMN2
GABRG2
NEFL
GABRA6
MAP4
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
BLALOCK_ALZHEIMERS_DISEASE_DN
MODULE_11
MODULE_66
MODULE_100
MODULE_137
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Orthotopic Xenograft Model of Ependymoma that Maintains Genomic Signature of the Primary Tumor
Ependymoma gene expression analysis - clinical stage analysis
Expression data from primary ependymoma surgical samples - recurrent vs. non-recurrent tumors
Gene expression in human ependynoma primary tumors
Mouse models of ependymoma - differences in cell lines and primary tumors
Explore Curated Studies Results
Literature
Most Relevant Literature
Clinically relevant molecular hallmarks of PFA ependymomas display intratumoral heterogeneity and co…
Disappearance of "Elongated Pony Tail Sign" Following Chemoradiotherapy in a Case of Primary Cerebel…
Extensive metastatic ependymoma with long-term progression-free survival with capecitabine plus temo…
Ependymomas of the spinal region in adults: Clinical and pathological features and MYCN expression l…
MYCN amplification in spinal ependymoma: A five-year retrospective study.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma
Antineoplaston Therapy in Treating Patients With Ependymoma
Carboplatin as a Radiosensitizer in Treating Childhood Ependymoma
Carboplatin and Bevacizumab for Recurrent Ependymoma
Everolimus for Children With Recurrent or Progressive Ependymoma
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ